Products
16745 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen Constant Leverage with ISIN code: CH1119067564 | Amgen | Constant Leverage | Long | ― | 293.861 | 6.07 | 0.050 | 6.12 | 1 | -2.25 % | 22.13 % | -29.50 % | 10 May. 2022 | |
| Amgen Constant Leverage with ISIN code: CH1197222909 | Amgen | Constant Leverage | Long | ― | 293.861 | 0.051 | 0.002 | 0.053 | 1 | -5.56 % | 41.67 % | -74.50 % | 23 Jun. 2022 | |
| Amgen Constant Leverage with ISIN code: CH1197222891 | Amgen | Constant Leverage | Long | ― | 293.861 | 0.43 | 0.020 | 0.45 | 1 | -4.44 % | 43.33 % | -62.28 % | 23 Jun. 2022 | |
| Amgen Constant Leverage with ISIN code: CH1197222883 | Amgen | Constant Leverage | Long | ― | 293.861 | 2.15 | 0.030 | 2.18 | 1 | -3.15 % | 33.54 % | -46.25 % | 23 Jun. 2022 | |
| Amgen Constant Leverage with ISIN code: CH1119067572 | Amgen | Constant Leverage | Short | ― | 293.861 | 0.9 | 0.020 | 0.92 | 1 | 0.00 % | -19.64 % | 23.29 % | 10 May. 2022 | |
| Amgen Constant Leverage with ISIN code: CH1345999275 | Amgen | Constant Leverage | Short | ― | 293.861 | 0.55 | 0.020 | 0.57 | 1 | -1.79 % | -29.49 % | 27.91 % | 18 Apr. 2024 | |
| Apple Constant Leverage with ISIN code: CH1197222834 | Apple | Constant Leverage | Long | ― | 230.53 | 8.04 | 0.020 | 8.06 | 1 | 0.88 % | 6.91 % | -5.85 % | 23 Jun. 2022 | |
| Apple Constant Leverage with ISIN code: CH1346746311 | Apple | Constant Leverage | Long | ― | 230.53 | 19.15 | 0.100 | 19.25 | 1 | 2.13 % | 4.36 % | -9.67 % | 7 May. 2024 | |
| Apple Constant Leverage with ISIN code: CH1346746329 | Apple | Constant Leverage | Long | ― | 230.53 | 19.4 | 0.100 | 19.5 | 1 | 3.19 % | 6.01 % | -14.91 % | 7 May. 2024 | |
| Apple Constant Leverage with ISIN code: CH1119067549 | Apple | Constant Leverage | Long | ― | 230.53 | 8.52 | 0.050 | 8.57 | 1 | 0.24 % | 4.67 % | -2.41 % | 10 May. 2022 | |
| Apple Constant Leverage with ISIN code: CH1197222842 | Apple | Constant Leverage | Long | ― | 230.53 | 2.04 | 0.020 | 2.06 | 1 | 0.99 % | 8.51 % | -10.53 % | 23 Jun. 2022 | |
| Apple Constant Leverage with ISIN code: CH1235293292 | Apple | Constant Leverage | Long | ― | 230.53 | 0.2 | 0.020 | 0.22 | 1 | -4.76 % | 0.00 % | -20.00 % | 10 Jan. 2023 | |
| Apple Constant Leverage with ISIN code: CH1290993885 | Apple | Constant Leverage | Long | ― | 230.53 | 0.54 | 0.020 | 0.56 | 1 | 0.00 % | 10.20 % | -22.86 % | 18 Apr. 2024 | |
| Apple Constant Leverage with ISIN code: CH1346746303 | Apple | Constant Leverage | Long | ― | 230.53 | 16.75 | 0.100 | 16.85 | 1 | 0.90 % | 2.76 % | -5.10 % | 7 May. 2024 | |
| Apple Constant Leverage with ISIN code: CH1346746691 | Apple | Constant Leverage | Long | ― | 230.53 | 4.63 | 0.030 | 4.66 | 1 | 3.12 % | 5.71 % | -14.89 % | 9 Jul. 2024 | |
| Apple Constant Leverage with ISIN code: CH1119067556 | Apple | Constant Leverage | Short | ― | 230.53 | 0.32 | 0.020 | 0.34 | 1 | -5.88 % | -8.57 % | -3.03 % | 10 May. 2022 | |
| Apple Constant Leverage with ISIN code: CH1246615590 | Apple | Constant Leverage | Short | ― | 230.53 | 0.11 | 0.020 | 0.13 | 1 | -8.33 % | -15.38 % | -8.33 % | 8 Jun. 2023 | |
| Apple Constant Leverage with ISIN code: CH1346000156 | Apple | Constant Leverage | Short | ― | 230.53 | 6.11 | 0.040 | 6.15 | 1 | -2.86 % | -6.57 % | 0.16 % | 9 Jul. 2024 | |
| Apple Constant Leverage with ISIN code: CH1210506130 | Apple | Constant Leverage | Short | ― | 230.53 | 0.061 | 0.002 | 0.063 | 1 | -3.17 % | -6.15 % | -1.61 % | 15 Sep. 2022 | |
| Apple Constant Leverage with ISIN code: CH1119065998 | Apple | Constant Leverage | Short | ― | 230.53 | 0.16 | 0.010 | 0.17 | 1 | -5.88 % | -11.11 % | -5.88 % | 1 Oct. 2021 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.